EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn’s disease

Antonino Andrea Blandino iD, Peter Caravan iD, Rocco Ricciardi, Liliana G Bordeianou, Hiroko Kunitake, Robert N Goldstone, Michael G Drage iD, M Lisa Zhang iD, Ashwin N Ananthakrishnan iD, Onofrio Antonio Catalano iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-025-07741-x ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Antonino Andrea Blandino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. Hauptthemen laut MEDLINE: Collagen, Crohn Disease, Magnetic Resonance Imaging, Multimodal Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Takeda Pharmaceuticals U.S.A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the feasibility and diagnostic performance of 68Ga-CBP8 PET/MR enterography for noninvasive detection of bowel collagen deposition and differentiation of inflammatory from fibrotic or mixed strictures in Crohn's disease. MATERIALS AND METHODS: Patients with stricturing Crohn's disease scheduled for bowel resection or endoscopic biopsy were prospectively enrolled. PET/MR enterography was performed after intravenous administration of 68Ga-collagen binding probe 8 (68Ga-CBP8). Focal radiotracer uptake was defined as activity exceeding local background and anatomically corresponding to an MR-identified bowel stricture. Surgical and biopsy specimens underwent blinded pathologic evaluation for fibrosis. Descriptive statistics, sensitivity and specificity were calculated to assess diagnostic performance. Differences in SUVmax and SUVmax stricture-to-uninvolved bowel ratio between fibrotic and non-fibrotic segments were evaluated using the Mann-Whitney U test, with p < 0.05 considered statistically significant. RESULTS: Five patients (4 M, 1 F; median age: 50; IQR: 11) with seven strictured bowel segments (median length: 24 mm; IQR: 14) were included. Five segments (71.4%) demonstrated focal 68Ga-CBP8 uptake and were pathologically confirmed as mixed inflammatory-fibrotic strictures. Two segments (28.6%) showed no significant uptake and were confirmed as strictures devoid of fibrosis. 68Ga-CBP8 PET/MR enterography achieved 100% sensitivity for mixed inflammatory-fibrotic strictures and 100% specificity for non-fibrotic strictures. SUVmax and SUVmax stricture-to-uninvolved bowel ratio were higher in fibrotic than non-fibrotic segments (median SUVmax: 2.29 vs. 1.01; median ratio: 2.36 vs. 0.88), although without statistically significant differences (both p = 0.095). CONCLUSION: 68Ga-CBP8 PET/MR enterography is a feasible noninvasive technique to assess bowel strictures in Crohn's disease and may enable differentiation of inflammatory and fibrotic components. TRIAL REGISTRATION: ClinicalTrials.gov, NCT06252493. Date of first enrollment: 19 December 2023. Registered: 2 February 2024 (retrospectively registered).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CollagenCrohn DiseaseMagnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyAdultFemaleHumansMaleMiddle AgedConstriction, PathologicDiagnosis, DifferentialFibrosisGallium RadioisotopesInflammation

Stichwörter der Autor:innen

68Ga-CBP8Bowel fibrosisCrohn’s diseaseIBDIntestinal stricturesPET/MR enterography

Substanzen

CollagenGallium Radioisotopes

Autor:innen und Institutionen

  • Department of Radiology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
  • Section of Radiology - Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University Hospital "Paolo Giaccone", Via del Vespro 129, Palermo, 90127, Italy.
  • A. A. Martinos Center for Biomedical Imaging and Institute for Innovation in Imaging, Department of Radiology, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA.
  • Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Surgery, Massachusetts General Hospital, Colorectal Surgery Program, Boston, MA, USA.
  • Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.

ORCID-Profile: Antonino Andrea Blandino, Peter Caravan, Michael G Drage, M Lisa Zhang, Ashwin N Ananthakrishnan, Onofrio Antonio Catalano

Förderung

  • Takeda Pharmaceuticals U.S.A.

Zitieren

APA

Blandino, A. A., Caravan, P., Ricciardi, R., Bordeianou, L. G., Kunitake, H., Goldstone, R. N., Drage, M. G., Zhang, M. L., Ananthakrishnan, A. N., & Catalano, O. A. (2026). Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn’s disease. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07741-x

Vancouver

Blandino AA, Caravan P, Ricciardi R, Bordeianou LG, Kunitake H, Goldstone RN, et al. Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07741-x

BibTeX
@article{Blandino2026,
  author = {Blandino, Antonino Andrea and Caravan, Peter and Ricciardi, Rocco and Bordeianou, Liliana G and Kunitake, Hiroko and Goldstone, Robert N and Drage, Michael G and Zhang, M Lisa and Ananthakrishnan, Ashwin N and Catalano, Onofrio Antonio},
  title = {Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn’s disease},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-025-07741-x}
}
Kostenlos starten →